Friday, 8 October 2021

A first? COVID antibody therapy with full-year protection is up for FDA authorization: AZD7442, is designed to be used as a preventive measure to boost immunity for up to one year after a single, intramuscular injection

A first? COVID antibody therapy with full-year protection is up for FDA authorization: AZD7442, is designed to be used as a preventive measure to boost immunity for up to one year after a single, intramuscular injection submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/3mGnkTV

No comments:

Post a Comment